Y-ECCO
@y_ecco_ibd
Y-ECCO committee members tweeting about IBD educational and research news. Any views expressed are personal and not official ECCO position.
ID: 749624625441759232
https://www.ecco-ibd.eu 03-07-2016 15:23:32
2,2K Tweet
3,3K Followers
3,3K Following
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…